US Patent 9840554 Antibodies against platelet-derived growth factor (PDGF)
Patent 9840554 was granted and assigned to AbbVie Inc. on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+328 characters)
Article
Patent abstract
Binding proteins that bind one or more of VEGF, PDGF and/or their receptors, including antibodies, CDR-grafted antibodies, humanized antibodies, binding fragments, fusion proteins, and bispecific or multispecific proteins thereof are disclosed. Also disclosed are methods of making and using the binding proteins.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Anca Clabbers0
Diana Bowley0
Feng Dong0
Jijie Gu0
Lorenzo Benatuil0
Lucia Eaton0
Matthew Rieser0
Ravi Chari0
Tariq Ghayur0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09840554 Antibodies against platelet-derived growth factor (PDGF) US Patent 9840554 Antibodies against platelet-derived growth factor (PDGF)
Infobox
Patent Number
098405540
Patent Number
98405540
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098405540
Date of Patent
December 12, 2017
0Patent Application Number
151837250
Date Filed
June 15, 2016
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09840554 Antibodies against platelet-derived growth factor (PDGF)
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09840554
Date of patent
December 12, 2017
Patent application number
15183725
Date Filed
June 15, 2016
Patent primary examiner
Find more entities like US Patent 9840554 Antibodies against platelet-derived growth factor (PDGF)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
